Copyright Reports & Markets. All rights reserved.

Global Newcastle Disease Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Newcastle Disease Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Live Vaccines
    • 1.3.3 Killed Vaccines
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Newcastle Disease Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Chicken
    • 1.4.3 Duck & Goose
    • 1.4.4 Other
  • 1.5 Global Newcastle Disease Vaccine Market Size & Forecast
    • 1.5.1 Global Newcastle Disease Vaccine Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Newcastle Disease Vaccine Sales Quantity (2020-2031)
    • 1.5.3 Global Newcastle Disease Vaccine Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Merial
    • 2.1.1 Merial Details
    • 2.1.2 Merial Major Business
    • 2.1.3 Merial Newcastle Disease Vaccine Product and Services
    • 2.1.4 Merial Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Merial Recent Developments/Updates
  • 2.2 CEVA
    • 2.2.1 CEVA Details
    • 2.2.2 CEVA Major Business
    • 2.2.3 CEVA Newcastle Disease Vaccine Product and Services
    • 2.2.4 CEVA Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 CEVA Recent Developments/Updates
  • 2.3 QYH Biotech
    • 2.3.1 QYH Biotech Details
    • 2.3.2 QYH Biotech Major Business
    • 2.3.3 QYH Biotech Newcastle Disease Vaccine Product and Services
    • 2.3.4 QYH Biotech Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 QYH Biotech Recent Developments/Updates
  • 2.4 Ringpu Biology
    • 2.4.1 Ringpu Biology Details
    • 2.4.2 Ringpu Biology Major Business
    • 2.4.3 Ringpu Biology Newcastle Disease Vaccine Product and Services
    • 2.4.4 Ringpu Biology Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Ringpu Biology Recent Developments/Updates
  • 2.5 Yebio
    • 2.5.1 Yebio Details
    • 2.5.2 Yebio Major Business
    • 2.5.3 Yebio Newcastle Disease Vaccine Product and Services
    • 2.5.4 Yebio Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Yebio Recent Developments/Updates
  • 2.6 Harbin Veterinary Research Institute
    • 2.6.1 Harbin Veterinary Research Institute Details
    • 2.6.2 Harbin Veterinary Research Institute Major Business
    • 2.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
    • 2.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
  • 2.7 Merck Animal Health
    • 2.7.1 Merck Animal Health Details
    • 2.7.2 Merck Animal Health Major Business
    • 2.7.3 Merck Animal Health Newcastle Disease Vaccine Product and Services
    • 2.7.4 Merck Animal Health Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Merck Animal Health Recent Developments/Updates
  • 2.8 DHN
    • 2.8.1 DHN Details
    • 2.8.2 DHN Major Business
    • 2.8.3 DHN Newcastle Disease Vaccine Product and Services
    • 2.8.4 DHN Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 DHN Recent Developments/Updates
  • 2.9 Zoetis
    • 2.9.1 Zoetis Details
    • 2.9.2 Zoetis Major Business
    • 2.9.3 Zoetis Newcastle Disease Vaccine Product and Services
    • 2.9.4 Zoetis Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Zoetis Recent Developments/Updates
  • 2.10 ChengDu Tecbond
    • 2.10.1 ChengDu Tecbond Details
    • 2.10.2 ChengDu Tecbond Major Business
    • 2.10.3 ChengDu Tecbond Newcastle Disease Vaccine Product and Services
    • 2.10.4 ChengDu Tecbond Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 ChengDu Tecbond Recent Developments/Updates
  • 2.11 Elanco (Lohmann)
    • 2.11.1 Elanco (Lohmann) Details
    • 2.11.2 Elanco (Lohmann) Major Business
    • 2.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Product and Services
    • 2.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Elanco (Lohmann) Recent Developments/Updates
  • 2.12 FATRO
    • 2.12.1 FATRO Details
    • 2.12.2 FATRO Major Business
    • 2.12.3 FATRO Newcastle Disease Vaccine Product and Services
    • 2.12.4 FATRO Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 FATRO Recent Developments/Updates
  • 2.13 CAVAC
    • 2.13.1 CAVAC Details
    • 2.13.2 CAVAC Major Business
    • 2.13.3 CAVAC Newcastle Disease Vaccine Product and Services
    • 2.13.4 CAVAC Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 CAVAC Recent Developments/Updates
  • 2.14 Vaksindo
    • 2.14.1 Vaksindo Details
    • 2.14.2 Vaksindo Major Business
    • 2.14.3 Vaksindo Newcastle Disease Vaccine Product and Services
    • 2.14.4 Vaksindo Newcastle Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Vaksindo Recent Developments/Updates

3 Competitive Environment: Newcastle Disease Vaccine by Manufacturer

  • 3.1 Global Newcastle Disease Vaccine Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Newcastle Disease Vaccine Revenue by Manufacturer (2020-2025)
  • 3.3 Global Newcastle Disease Vaccine Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Newcastle Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Newcastle Disease Vaccine Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Newcastle Disease Vaccine Manufacturer Market Share in 2024
  • 3.5 Newcastle Disease Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Newcastle Disease Vaccine Market: Region Footprint
    • 3.5.2 Newcastle Disease Vaccine Market: Company Product Type Footprint
    • 3.5.3 Newcastle Disease Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Newcastle Disease Vaccine Market Size by Region
    • 4.1.1 Global Newcastle Disease Vaccine Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Newcastle Disease Vaccine Consumption Value by Region (2020-2031)
    • 4.1.3 Global Newcastle Disease Vaccine Average Price by Region (2020-2031)
  • 4.2 North America Newcastle Disease Vaccine Consumption Value (2020-2031)
  • 4.3 Europe Newcastle Disease Vaccine Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Newcastle Disease Vaccine Consumption Value (2020-2031)
  • 4.5 South America Newcastle Disease Vaccine Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Newcastle Disease Vaccine Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Newcastle Disease Vaccine Sales Quantity by Type (2020-2031)
  • 5.2 Global Newcastle Disease Vaccine Consumption Value by Type (2020-2031)
  • 5.3 Global Newcastle Disease Vaccine Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Newcastle Disease Vaccine Sales Quantity by Application (2020-2031)
  • 6.2 Global Newcastle Disease Vaccine Consumption Value by Application (2020-2031)
  • 6.3 Global Newcastle Disease Vaccine Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Newcastle Disease Vaccine Sales Quantity by Type (2020-2031)
  • 7.2 North America Newcastle Disease Vaccine Sales Quantity by Application (2020-2031)
  • 7.3 North America Newcastle Disease Vaccine Market Size by Country
    • 7.3.1 North America Newcastle Disease Vaccine Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Newcastle Disease Vaccine Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Newcastle Disease Vaccine Sales Quantity by Type (2020-2031)
  • 8.2 Europe Newcastle Disease Vaccine Sales Quantity by Application (2020-2031)
  • 8.3 Europe Newcastle Disease Vaccine Market Size by Country
    • 8.3.1 Europe Newcastle Disease Vaccine Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Newcastle Disease Vaccine Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Newcastle Disease Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Newcastle Disease Vaccine Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Newcastle Disease Vaccine Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Newcastle Disease Vaccine Sales Quantity by Type (2020-2031)
  • 10.2 South America Newcastle Disease Vaccine Sales Quantity by Application (2020-2031)
  • 10.3 South America Newcastle Disease Vaccine Market Size by Country
    • 10.3.1 South America Newcastle Disease Vaccine Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Newcastle Disease Vaccine Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Newcastle Disease Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Newcastle Disease Vaccine Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Newcastle Disease Vaccine Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Newcastle Disease Vaccine Market Drivers
  • 12.2 Newcastle Disease Vaccine Market Restraints
  • 12.3 Newcastle Disease Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Newcastle Disease Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Newcastle Disease Vaccine
  • 13.3 Newcastle Disease Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Newcastle Disease Vaccine Typical Distributors
  • 14.3 Newcastle Disease Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 345 million in 2024 and is forecast to a readjusted size of USD 430 million by 2031 with a CAGR of 3.2% during review period.
    Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
    Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
    Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
    This report is a detailed and comprehensive analysis for global Newcastle Disease Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Newcastle Disease Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2020-2031
    Global Newcastle Disease Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2020-2031
    Global Newcastle Disease Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2020-2031
    Global Newcastle Disease Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Newcastle Disease Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Newcastle Disease Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN, Zoetis, ChengDu Tecbond, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Newcastle Disease Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Live Vaccines
    Killed Vaccines
    Market segment by Application
    Chicken
    Duck & Goose
    Other
    Major players covered
    Merial
    CEVA
    QYH Biotech
    Ringpu Biology
    Yebio
    Harbin Veterinary Research Institute
    Merck Animal Health
    DHN
    Zoetis
    ChengDu Tecbond
    Elanco (Lohmann)
    FATRO
    CAVAC
    Vaksindo
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Newcastle Disease Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Newcastle Disease Vaccine, with price, sales quantity, revenue, and global market share of Newcastle Disease Vaccine from 2020 to 2025.
    Chapter 3, the Newcastle Disease Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Newcastle Disease Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Newcastle Disease Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Newcastle Disease Vaccine.
    Chapter 14 and 15, to describe Newcastle Disease Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now